However, considering that IDH1-R132H and IDH2-R172K are the most common variants if the two variants specified were not detected for tumors, we still encourage doctors to regard them as IDH wildtype gliomas and perform clinical treatment, especially when immediate judgment is required. Here, IDH2 is linked to central nervous system cancer.